Total Funding
64
68
Total FundingPost-IPO Debt raised
Growth Score 64 in past quarter
-17 pts
Heat Score 68 in past quarter
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
57847
ANI Pharmaceuticals manufactures oral solid dose products, as well as liquids and topicals.
Acquired by 

Meridian Venture Partners
- Thomas Haughey: Chairman of the Board
- Krista Davis: SVP, Chief Human Resources Officer
About the Company
ANI Pharmaceuticals is a specialty pharmaceuticals industry that develops, manufactures and markets top-quality prescription pharmaceuticals, made in the U.S.A. ANI manufactures oral solid dose products, as well as liquids and topicals, including narcotics and those that must be manufactured in a fully contained environment due to their potency
and/or toxicity. ANI also performs contract manufacturing for other pharmaceutical companies.

